Menopace® nutrient therapy: An alternative approach to pharmaceutical treatments for menopause

International Journal of Fertility and Women's Medicine

Volumn 51, Issue 3, 2006, Pages 125-129

  Kirby, Russell S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Evidence based practice; Menopause; Nutrient therapy; Uncontrolled prospective studies

Indexed keywords

TRACE ELEMENT; VITAMIN;

ALTERNATIVE MEDICINE; CONTROLLED CLINICAL TRIAL; DIET THERAPY; EMOTIONAL DISORDER; ESTROGEN THERAPY; FEMALE; HOT FLUSH; HUMAN; INDIA; MENOPAUSE; METHODOLOGY; REVIEW; RUSSIAN FEDERATION; TREATMENT OUTCOME; UNITED KINGDOM; WOMEN'S HEALTH;

AFFECTIVE SYMPTOMS; COMPLEMENTARY THERAPIES; CONTROLLED CLINICAL TRIALS; ESTROGEN REPLACEMENT THERAPY; FEMALE; GREAT BRITAIN; HOT FLASHES; HUMANS; INDIA; MENOPAUSE; NUTRITION THERAPY; RESEARCH DESIGN; RUSSIA; TRACE ELEMENTS; TREATMENT OUTCOME; VITAMINS; WOMEN'S HEALTH;

EID: 39049185027     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Speroff L, Fritz MA: Clinical and Gynecologic Endocrinology and Infertility, 7th Ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2004.
2. Rossouw JE, Anderson GL, Prentice RL, et al: Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288:321-333, 2002. (Pubitemid 34761611)
3. Grady D, Herrington D, Bittner V, et al, HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288:49-57, 2002. (Pubitemid 34705518)
4. Million Women Study Collaborators: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-427, 2003.
5. Naftolin F, Taylor HS, Karas R, et al: The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertil Steril 81(6):1498-1501, 2004. (Pubitemid 38748989)
6. Machens K, Schmidt-Gollwitzer K: Issues to debate on the Women's Health Initiative (WHI) study. Hormone replacement therapy: an epidemiological dilemma? Hum Reprod 18(10):1992-1999, 2003.
7. Speroff L: A clinician's review of the WHI-related literature Int J Fertil Women's Med 49:252-267, 2004.
8. Warren MP, Shortle B, Dominguez JE: Use of alternative therapies in menopause. Best Pract Res Clin Obstet Gynecol 16:411-448, 2002. (Pubitemid 41132051)
9. Wylie-Rossett J: Menopause, micronutrients, and hormone therapy. Am J Clin Nutr 81:1223S-1231S, 2005.
10. Huntley AL, Ernst E: A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause 10:465-476, 2003.
11. Irving K, Sapirstein G: Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention & Treatment 1, 1, 1998. (www.journals.apa.org/prevention/volume1/toc-jun26-98.html)
12. Schneider HPG: The quality of life in the postmenopausal woman. Best Practice & Research Clinical Obstetrics and Gynecology 16:395-409, 2002.
13. Sackett DL, Straus SE, Richardson WS, et al: Evidence-Based Medicine: How to Practice and Teach EBM, Second Edition. Edinburgh: Churchill Livingstone, 2000.
14. Report of the U.S. Preventive Services Task Force. Guide to Clinical Preventive Services, Second Edition. Alexandria, VA: International Medical Publishing, 1996.
15. Doll R, Hill AB.: Smoking and carcinoma of the lung: Preliminary report. Br Med J 2:739-748, 1950.
16. Carter KC: SemmelWeis and his predecessors. Med Hist 25(1): 57-72, 1981.